Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00104598 · ClinicalTrials.gov registry record · NA
Framing Messages for Smoking Cessation With Bupropion - 6
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
NCT00104598 is a NA study that has completed, run by Yale University. The registered enrollment target is 252 participants.
The verdict
NCT00104598, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
Study Summary
This is a randomized study of message framing in individuals beginning a smoking cessation program utilizing bupropion SR and brief counseling, videos, and pamphlets.
Interventions
- DRUG Bupropion
- BEHAVIORAL Smoking Abstinence Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2000-09 |
| Est. Completion | 2006-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00104598
The ClinicalTrials.gov registry entry for NCT00104598 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupropion is the first listed.
NCT00104598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00104598 about?
NCT00104598 is a clinical study titled "Framing Messages for Smoking Cessation With Bupropion - 6". This is a randomized study of message framing in individuals beginning a smoking cessation program utilizing bupropion SR and brief counseling, videos, and pamphlets.
What is the current status of trial NCT00104598?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2000-09. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00104598?
The interventions under investigation include: Bupropion (DRUG), Smoking Abstinence Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00104598?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.